IL6 and metabolic dysfunction-associated steatotic liver disease: Adiponectin, with its insulin-sensitizing and anti-inflammatory effects in NAFLD model, was one of the main factors to prevent fibrosis by reducing the concentrations of TNF-α and IL-6, and consequently, inhibit the inflammatory response.